Tuesday, December 5, 2023

ParkwayLife Reit - She has managed to bounce-off from 3.40 and is now hovering at 3.47 to 3.51 level looks rather interesting!

 

She has managed to bounce-off from 3.40 and is now hovering at 3.47 to 3.51 level looks rather interesting! 



Yield is about 4.2% at 3.47.

Today nibbled a bit at 3.47. Last sold off at 3.63(EP 3.50).

Aiming for kopi money as reit has rebounded dus to rate paused on November.  If December another rate paused then we may see reit counter rising up further.

Pls dyodd.

She has broken down 3.48 level looks like Bear is in control! We may see further selling down pressure!



Likely to go down to revisit 3.34-3.30.

Pls dyodd. 

She had retreated from 3.63 to go down to touch 3.51 this morning,  luckily I had secured the profit and another opportunity is back again if she goes back to 3.50 and below! 



Pls dyodd. 


Locked in kopi lui yesterday at 3.62.



Waiting for the next opportunity!

Pls dyodd. 


 Entered a bit at 3.50.



Kopi money is coming! 

Queueing 3.65 to lock in the profit!

Pls dyodd. 


 I think boat is back! 



At 3.46, yield is about 4.21%. This is like a FD fixed income product that has a long WALE seem rather interesting!

It has been corrected from above 4.50 to 3.46, I think good price is back! 

Please dyodd.

 She has managed to recover from the low of 3.34 and rises higher to touch 3.56 and taking a breather to close at 3.50. Looks like the Bull has managed to take control of the Bear. This is rather bullish!



Short term wise  I think likely to rise up to retest 3.56-3.57. A nice breakout smoothly may drive the price higher towards 3.70 and beyond!


Pls dyodd. 


I think the results is not bad!

Gross Revenue is up 24.6% to 110.89m and NPI is up 26.2% to 104.5m.





Dpu is up marginally 1.5% to 3.7 cents versus 3.645 cents last quarter. 

Nine months dpu is up 2.8% to 10.99 cents versus 10.79 cents last year. 

At 3.36, yield is about 4.36% estimating yearly dpu of 14.69 cents.

Not a call to buy or sell!

Pls dyodd. 

Parkway Life REIT ("PLife REIT") is one of Asia's largest listed healthcare REITs. It invests in income-producing real estate and real estate-related assets used primarily for healthcare and healthcare-related purposes. As at 31 March 2023, PLife REIT's total portfolio size stands at 61 properties totalling approximately S$2.20 billion.




Mission

To deliver regular and stable distributions and achieve long-term growth for our Unitholders.

Our Growth Strategy

PLife REIT is firmly guided by its principle of staying prudent and focused in its growth strategy, focusing on:

As at 31 March 2023, PLife REIT has successfully expanded its total portfolio to 61 properties, including hospitals and medical centres in Singapore, Malaysia and 57 healthcare-related assets in Japan, worth approximately S$2.20 billion1.

Targeted Investment

As PLife REIT continues to be on the lookout for high-quality, yield-accretive acquisition opportunities in the region, it remains discerning and prudent in its approach of acquiring assets that are not only value -generating, but also preserve the long-term defensiveness of the overall portfolio.


Proactive Asset Management




Through proactive asset management, PLife REIT constantly strives to maximise portfolio performance in order to enhance the revenue-generating ability of its properties and ensure sustainable earnings for its Unitholders.

As part of PLife REIT’s initiative to drive organic growth and foster good Landlord-Lessee relationships, it seeks to work closely with its Lessees to understand their operational requirements and embark on Asset Enhancement Initiatives (“AEIs”) which are tailored to suit the needs of its healthcare operators and end users of the properties. Such strategic collaborative arrangements serve to benefit all parties and promote greater revenue sustainability for PLife REIT.

PLife REIT has, leveraging on its clustering/ partnering approach and good landlord-lessee relationships, successfully expanded its nursing home portfolio and completed 14 AEIs in Japan since its maiden entry in 2008 and one at its Malaysia property (Gleneagles Intan Medical Centre Kuala Lumpur).

Moving forward, PLife REIT remains committed to exploring and rolling out more of such AEIs across its entire portfolio to extract the greatest value from its properties. To further strengthen PLife REIT's earnings resiliency, it is also focused on consolidation efforts for its Japan portfolio to optimise operating synergies and achieve greater cost savings.

Capital and Financial Management

PLife REIT aims to maintain a strong financial position through prudent and dynamic capital and financial management, to ensure continuous access to funding at optimal cost, maintain stable distributions to Unitholders and achieve a steady net asset value.

As at 31 March 2023, PLife REIT's gearing was 37.5% which complied with the stipulated Aggregate Leverage limit1. The interest coverage ratio stood at 15.6 times2.

Dynamic liability and liquidity risk management

PLife REIT adopts a dynamic and pro-active approach for its liability and liquidity risk management. Our key liability and funding management strategies in support of our regional growth aspirations are:

1) To achieve diversified funding sources at an optimal cost
Diversify our funding sources from a panel of high quality banks, establishing and maintaining our Debt Issuance Programme and other financing sources to attain varied liability tenure, with the end objective of maintaining the most optimal financing cost mix.

2) To enhance the defensiveness of PLife REIT's Balance Sheet strength
Dynamically manage our debt maturity profile to ensure well-spread debt maturities and at the same time, to maintain an optimal capital structure.

Tactical approaches adopted in view of the above strategies are:

a) Conscientious effort in lengthening and spreading out the debt maturity period;
b) Cultivating and maintaining a panel of key banks to support our long term growth;
c) Establishing alternative source of fund. In this respect, PLife REIT, through its wholly-owned subsidiary, Parkway Life MTN Pte Ltd (the “MTN Issuer”), put in place a S$500 million Multicurrency Debt Issuance Programme to provide PLife REIT with the flexibility to tap various types of capital market products including issuance of perpetual securities when needed. On 6 December 2022, the Group issued a 6-year JPY5.0 billion and a maiden 7-year JPY6.04 billion fixed rate notes to pre-emptively refinance existing fixed rate notes due in 2023 and term out the JPY short-term loans drawn down for acquisition financing. As at 31 March 2023, there were five series of outstanding unsecured fixed rate




notes amounted to JPY19.84 billion3 (approximately S$202.6 million) issued under the Debt Issuance Programme, which diversified PLife REIT’s funding sources.
d) Minimising near-term refinancing risk through pre-emptive terming out current debts. With the new notes issuance, PLife REIT has effectively managed its debt maturity profile with no immediate long-term debt refinancing needs until February 2024.

Financial risk management

PLife REIT adopts prudent financial risk management to manage the exposure to interest rate risk and foreign currency risk. Our policy is to hedge at least 50% (up to 100%) of all financial risks.

Interest rate risk is managed on an ongoing basis with the primary objective of limiting the extent to which net interest expenses could be affected by adverse movements in interest rates, by hedging the long term committed borrowings through the use of interest rate hedging financial instruments. For the foreign exchange ("Forex") risk management, we strive to hedge Forex risk on principal which will allow PLife REIT to maintain a stable net asset value, as the Forex fluctuation on foreign asset will offset the Forex fluctuation of the hedging instrument. We also aim to hedge the Forex risk on net overseas income which will provide PLife REIT with stability in distributable income, as PLife REIT will be shielded from exchange rate fluctuation on foreign income.

As at 31 March 2023, the Group has put in place Japanese Yen forward exchange contracts till 1Q 2027 and about 78% of interest rate exposure is hedged.

Chart wise,  bullish 

 

Parkway Life REIT ("PLife REIT") is one of Asia's largest listed healthcare REITs. It invests in income-producing real estate and real estate-related assets used primarily for healthcare and healthcare-related purposes. As at 31 March 2023, PLife REIT's total portfolio size stands at 61 properties totalling approximately S$2.20 billion.

Mission

To deliver regular and stable distributions and achieve long-term growth for our Unitholders.

Our Growth Strategy

PLife REIT is firmly guided by its principle of staying prudent and focused in its growth strategy, focusing on:

As at 31 March 2023, PLife REIT has successfully expanded its total portfolio to 61 properties, including hospitals and medical centres in Singapore, Malaysia and 57 healthcare-related assets in Japan, worth approximately S$2.20 billion1.

Targeted Investment

As PLife REIT continues to be on the lookout for high-quality, yield-accretive acquisition opportunities in the region, it remains discerning and prudent in its approach of acquiring assets that are not only value -generating, but also preserve the long-term defensiveness of the overall portfolio.


Proactive Asset Management

Through proactive asset management, PLife REIT constantly strives to maximise portfolio performance in order to enhance the revenue-generating ability of its properties and ensure sustainable earnings for its Unitholders.

As part of PLife REIT’s initiative to drive organic growth and foster good Landlord-Lessee relationships, it seeks to work closely with its Lessees to understand their operational requirements and embark on Asset Enhancement Initiatives (“AEIs”) which are tailored to suit the needs of its healthcare operators and end users of the properties. Such strategic collaborative arrangements serve to benefit all parties and promote greater revenue sustainability for PLife REIT.

PLife REIT has, leveraging on its clustering/ partnering approach and good landlord-lessee relationships, successfully expanded its nursing home portfolio and completed 14 AEIs in Japan since its maiden entry in 2008 and one at its Malaysia property (Gleneagles Intan Medical Centre Kuala Lumpur).

Moving forward, PLife REIT remains committed to exploring and rolling out more of such AEIs across its entire portfolio to extract the greatest value from its properties. To further strengthen PLife REIT's earnings resiliency, it is also focused on consolidation efforts for its Japan portfolio to optimise operating synergies and achieve greater cost savings.

Capital and Financial Management

PLife REIT aims to maintain a strong financial position through prudent and dynamic capital and financial management, to ensure continuous access to funding at optimal cost, maintain stable distributions to Unitholders and achieve a steady net asset value.

As at 31 March 2023, PLife REIT's gearing was 37.5% which complied with the stipulated Aggregate Leverage limit1. The interest coverage ratio stood at 15.6 times2.

Dynamic liability and liquidity risk management

PLife REIT adopts a dynamic and pro-active approach for its liability and liquidity risk management. Our key liability and funding management strategies in support of our regional growth aspirations are:

1) To achieve diversified funding sources at an optimal cost
Diversify our funding sources from a panel of high quality banks, establishing and maintaining our Debt Issuance Programme and other financing sources to attain varied liability tenure, with the end objective of maintaining the most optimal financing cost mix.

2) To enhance the defensiveness of PLife REIT's Balance Sheet strength
Dynamically manage our debt maturity profile to ensure well-spread debt maturities and at the same time, to maintain an optimal capital structure.

Tactical approaches adopted in view of the above strategies are:

a) Conscientious effort in lengthening and spreading out the debt maturity period;
b) Cultivating and maintaining a panel of key banks to support our long term growth;
c) Establishing alternative source of fund. In this respect, PLife REIT, through its wholly-owned subsidiary, Parkway Life MTN Pte Ltd (the “MTN Issuer”), put in place a S$500 million Multicurrency Debt Issuance Programme to provide PLife REIT with the flexibility to tap various types of capital market products including issuance of perpetual securities when needed. On 6 December 2022, the Group issued a 6-year JPY5.0 billion and a maiden 7-year JPY6.04 billion fixed rate notes to pre-emptively refinance existing fixed rate notes due in 2023 and term out the JPY short-term loans drawn down for acquisition financing. As at 31 March 2023, there were five series of outstanding unsecured fixed rate




notes amounted to JPY19.84 billion3 (approximately S$202.6 million) issued under the Debt Issuance Programme, which diversified PLife REIT’s funding sources.
d) Minimising near-term refinancing risk through pre-emptive terming out current debts. With the new notes issuance, PLife REIT has effectively managed its debt maturity profile with no immediate long-term debt refinancing needs until February 2024.

Financial risk management

PLife REIT adopts prudent financial risk management to manage the exposure to interest rate risk and foreign currency risk. Our policy is to hedge at least 50% (up to 100%) of all financial risks.

Interest rate risk is managed on an ongoing basis with the primary objective of limiting the extent to which net interest expenses could be affected by adverse movements in interest rates, by hedging the long term committed borrowings through the use of interest rate hedging financial instruments. For the foreign exchange ("Forex") risk management, we strive to hedge Forex risk on principal which will allow PLife REIT to maintain a stable net asset value, as the Forex fluctuation on foreign asset will offset the Forex fluctuation of the hedging instrument. We also aim to hedge the Forex risk on net overseas income which will provide PLife REIT with stability in distributable income, as PLife REIT will be shielded from exchange rate fluctuation on foreign income.

As at 31 March 2023, the Group has put in place Japanese Yen forward exchange contracts till 1Q 2027 and about 78% of interest rate exposure is hedged.

Chart wise,  bearish mode!



Looks like gd price is back!

With bullish pin bar appearing on the chart we may see a throw-back reaction from the current price level of 3.74.

NAV is about 2.33.

Yearly dividend is about 14.5cents.

Yield is about 3.87 % based on current price of 3.74

Not a call to buy or sell!

Please dyodd. 






Monday, December 4, 2023

DBS - She has broken down the recent low of 31.49 thisbis rather negative likely to see her going down to test 30.50 than 30.30.

 She is trading below 31.49 support turn resistance doesn't look good!



Likely to breakdown 31.00 and go down to 30.50 Than 30.30. 

Pls dyodd. 

Cautious mode!



She has broken down the recent low of 31.49 seem rather Negative and this bearish trend may continue to go further down to test 30.50 than 30.30/30.00.

Pls dyodd.

High probability she may test 31.49 again! Breaking down plus high volume we may see her going further down to test 30.86 than 30.30.



Pls dyodd.  

Chart wise bearish mode!

I think is good to monitor and see if see is going down to retest 31.49.



Breaking down 31.49 plus high volume would be rather Negative and we may see her going further down to test 30.86 and below.

Pls dyodd.

 Low can Go Lower!

Cheap can become even cheaper!

 I Think Don't depend too much on the dividend which might not be guaranteed!

Rate cut might be happening next year!



Chart wise, bearish mode!

High chance it may go down to test 30.86 than 30.30 and 29.90.

Pls dyodd.


Chart wise,  bearish mode!



If 32.87 cannot hold,  then we may see her going further down to test 32.00 than 31.98 with extension to 30.30.

Pls dyodd.

 I think price is holding up well and may retest 34.55 due to dividend of 0.48.

Please dyodd.



Impressive set of financial numbers for 2nd quarter 2023.





Net profit increase 48% to a record earnings of 2.69b as total net income crosses 5b.



Declared interim dividend of 0 48. Versus 0.42 last quarter. Awesome. 

XD 11 August.  Pay date 24 August.


EPS increase 4.02% from 2.80 to 4.15.

NAV also increase 21% from 20.78 to 21.85.

Fantastic! I think price may gap up !



Hopefully,  it may stay above 34.00 with this stellar sets of financial results!

Please dyodd.



DBS - High probability she may breakdown 31.49 and go further down to test 30.86 than 30.30! Cautious mode!

High probability she may test 31.49 again! Breaking down plus high volume we may see her going further down to test 30.86 than 30.30.



Pls dyodd.  

Chart wise bearish mode!

I think is good to monitor and see if see is going down to retest 31.49.



Breaking down 31.49 plus high volume would be rather Negative and we may see her going further down to test 30.86 and below.

Pls dyodd.

 Low can Go Lower!

Cheap can become even cheaper!

 I Think Don't depend too much on the dividend which might not be guaranteed!

Rate cut might be happening next year!



Chart wise, bearish mode!

High chance it may go down to test 30.86 than 30.30 and 29.90.

Pls dyodd.


Chart wise,  bearish mode!



If 32.87 cannot hold,  then we may see her going further down to test 32.00 than 31.98 with extension to 30.30.

Pls dyodd.

 I think price is holding up well and may retest 34.55 due to dividend of 0.48.

Please dyodd.



Impressive set of financial numbers for 2nd quarter 2023.





Net profit increase 48% to a record earnings of 2.69b as total net income crosses 5b.



Declared interim dividend of 0 48. Versus 0.42 last quarter. Awesome. 

XD 11 August.  Pay date 24 August.


EPS increase 4.02% from 2.80 to 4.15.

NAV also increase 21% from 20.78 to 21.85.

Fantastic! I think price may gap up !



Hopefully,  it may stay above 34.00 with this stellar sets of financial results!

Please dyodd.



Saturday, December 2, 2023

DBS - Chart wise, bearish mode! Will she continue to trend down and revisit 31.49! Breaking down would be rather Negative! Do take note!

Chart wise bearish mode!

I think is good to monitor and see if see is going down to retest 31.49.



Breaking down 31.49 plus high volume would be rather Negative and we may see her going further down to test 30.86 and below.

Pls dyodd.

 Low can Go Lower!

Cheap can become even cheaper!

 I Think Don't depend too much on the dividend which might not be guaranteed!

Rate cut might be happening next year!



Chart wise, bearish mode!

High chance it may go down to test 30.86 than 30.30 and 29.90.

Pls dyodd.


Chart wise,  bearish mode!



If 32.87 cannot hold,  then we may see her going further down to test 32.00 than 31.98 with extension to 30.30.

Pls dyodd.

 I think price is holding up well and may retest 34.55 due to dividend of 0.48.

Please dyodd.



Impressive set of financial numbers for 2nd quarter 2023.





Net profit increase 48% to a record earnings of 2.69b as total net income crosses 5b.



Declared interim dividend of 0 48. Versus 0.42 last quarter. Awesome. 

XD 11 August.  Pay date 24 August.


EPS increase 4.02% from 2.80 to 4.15.

NAV also increase 21% from 20.78 to 21.85.

Fantastic! I think price may gap up !



Hopefully,  it may stay above 34.00 with this stellar sets of financial results!

Please dyodd.



Friday, December 1, 2023

Venture - Wow! Yesterday strong buying activities pushing the price higher I thought could be company bought back share yesterday but it isnt this show that market is in favor of the company mandate of buying back share up to 10m share, Awesome! Likely to see further price action! Bullish Indication!

Yesterday,  closed well at 13.02 plus high volume Up 49 cents looks rather bullish!



I think likely to clear 13.15 and rises higher to 14 than 14.30 with extension to 16.38.

Pls dyodd.


Quote:

VENTURE Corporation said on Thursday (Nov 30) that its board of directors has established a share buyback plan to purchase up to 10 million ordinary shares of the company.

This plan was authorised by the board on Nov 29, following the approval of Venture’s shareholders of the share purchase mandate at the annual general meeting on Apr 27, the company said in a bourse filing.

Under the mandate, the company can buy up to about 14.5 million shares, which translates to 5 per cent of the total number of issued shares of the company as at the date of the mandate.


Solid! This company cash rich therefore is able to buy back share! Awesome!


Likely to see price rising up to test 13.30 soon!

I am Targeting it can reach 15 to 16 dollars.  


Pls dyodd.

21st November 2023:

 TA wise, she is gaining strength and likely rise up to reclaim 13.30.



A nice crossing over of 13.30 smoothly we may likely see her moving ip towards 14.25.

Pls dyodd. 

Chart wise,  bullish mode!

I think she may rise up to test 13.30.



A nice breakout smoothly plus high volume we may see her rising up to test 15.10 than 16.00 and 16.40.

Yearly Dividend is 0.75.

Yield is 5.88% at 12.88.

Pls dyodd. 


TA wise, bullish mode!

This morning she has manged to cross over the resistance level at 12.50 plus good volume this is rather positive!



Short term wise,  I think likely to rise up to test 13.00 than 13.30 with extension to 14.00 than 14.36.

Not a call to buy or sell!

Pls dyodd. 





The recent 3rd quarter results is within expectations. 

9 months Net Profit is down 25.2% to 203.3m.

Net cash on hands increase to 956.5m.

I think cash per share is more than 3.00.